Skip to main content
GRAL logo

GRAL

GRAIL, Inc.
$71.96 -2.40 (-3.23%) At close · Jul 16
Market Cap
$3.09B
Shares
42,916,593

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$147.17M +17.2%
FY2025 Revenue FY2022–FY2025
Net Income
-$408.35M +79.9%
FY2025 Net Income FY2022–FY2025
Operating Margin
-381.98% +1361pp
FY2025 Operating Margin FY2022–FY2025
Diluted EPS
-$11.11 +82.5%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
-$299.01M +48.2%
FY2025 Operating Cash Flow FY2022–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022
$156.12M $147.17M $125.6M $93.11M $55.55M
$190.19M $195.79M $322.38M $338.75M $329.58M
$112.38M $116.69M $153.96M $162.29M $122.33M
$156.8M $159.1M $213.86M $200.27M $174.11M
$133.89M $133.89M $133.89M $133.89M $138.33M
$700.44M $709.34M $2.31B $1.61B $5.5B
-$544.32M -$562.16M -$2.19B -$1.52B -$5.44B
-381.98% -1743.03% -1627.61% -9798.18%
$28.86M $28.65M $26.73M $7.95M $1.74M
$28.71M $27.66M $26.8M $7.75M $1.5M
-$515.62M -$534.5M -$2.16B -$1.51B -$5.44B
-$120.29M -$126.15M -$135.36M -$41.95M -$42.29M
-$395.33M -$408.35M -$2.03B -$1.47B -$5.4B
-277.47% -1613.92% -1574.23% -9719.35%
-$395.12M -$407.15M -$2.03B -$1.47B -$5.4B
USD/shares -$11.11 -$63.54 -$47.21 -$173.89
USD/shares -$11.11 -$63.54 -$47.21 -$173.89
shares 36.75M 31.9M 31.05M 31.05M
shares 36.75M 31.9M 31.05M 31.05M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Diagnostics & Research median 2.94×
EV/EBIT
Diagnostics & Research median 31.74×
P/E (TTM)
Diagnostics & Research median 32.56×

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2023-01-01
Screening Revenue $138,601,000 $108,627,000 $74,999,000 $39,817,000
Developmental Services Revenue $8,571,000 $16,968,000 $18,106,000 $15,733,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2023-01-01
Reportable Segment -$562,163,000 -$2,189,158,000 -$1,515,382,000 -$5,442,890,000
Key facts CIK 1699031 CUSIP 384747101 13F (30d) 33 filings 31 filers Visit website Investor relations